SGH
PDLI

Schonfeld Group Holdings’s PDL BioPharma, Inc. PDLI Stock Holding History

Schonfeld Group Holdings’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-18,899
Closed -$157K – 502
2014
Q1 		$157K Buy
+18,899
New +$162K 0.04% 504

Other funds holding PDLI

Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Schonfeld Group Holdings's PDLI Position: Q2 2014 in Review

Schonfeld Group Holdings sold out of PDL BioPharma, Inc. (PDLI) in Q2 2014, closing a stake of 18,899 shares — an estimated $157K sold.

Schonfeld Group Holdings first reported a position in PDLI in Q1 2014 and held it in 1 quarter. The position peaked at $157K in Q1 2014. 222 funds tracked by Wall St. Rank hold PDLI as of Q2 2014.

  • Schonfeld Group Holdings reported no remaining PDL BioPharma, Inc. position as of Q2 2014 after selling out during the quarter.
  • Schonfeld Group Holdings sold 18,899 PDL BioPharma, Inc. shares in Q2 2014, an estimated $157K.
  • Schonfeld Group Holdings first reported a position in PDL BioPharma, Inc. in Q1 2014 and held it in 1 quarter.
  • Schonfeld Group Holdings's PDL BioPharma, Inc. position peaked at $157K in Q1 2014.
  • 222 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2014.

Based on Schonfeld Group Holdings's 13F filing for Q2 2014, filed 15 Aug 2014.